Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2301studies shown
Showing 37-48 of 2,301
Biological study icon
RecruitingNCT04751331

Neural Response to Inflammatory Challenge in Major Depressive Disorder

This study is comparing LPS with placebo for people with depression. Participants receive LPS or placebo and complete study visits and assessments.

Remote / online
Why is this study shown?

This study is directly about Depression.

DepressionBiologicalFrom 18 Years to 65 Years
Countries
United States
Sponsor
Laureate Institute for Brain Research, Inc.
Condition
Depression
Behavioral study icon
RecruitingNCT06695767

Neurobehavioral Therapy For Epilepsy And Major Depressive Disorder

This study is looking at whether Neurobehavioral therapy can help people with depression or Epilepsy. Participants take part in Neurobehavioral therapy and complete follow-up assessments.

Remote / online
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralOver 18 Years
Countries
United States
Sponsor
The University of Texas Health Science Center, Houston
Condition
Depression
Drug study icon
RecruitingNCT03065335

Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder

This study is comparing Ketamine with placebo for people with depression. Participants receive Ketamine or placebo and complete study visits and assessments.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States
Sponsor
National Institute of Mental Health (NIMH)
Condition
Depression
Device study icon
RecruitingNCT04556890

Pain and Major Depressive Disorder

This study is looking at examine the effects of brain stimulation on pain symptoms associated with Major depressive disorder for people with depression or Chronic Pain. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 75 Years
Countries
United States
Sponsor
University of California, Los Angeles
Condition
Depression
Drug study icon
RecruitingNCT06592833

Psilocybin With Pimavanserin Compared to Psilocybin Alone for Major Depressive Disorder

This study is comparing Psilocybin with placebo for people with depression. Participants receive Psilocybin or placebo and complete study visits and assessments.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 21 Years to 80 Years
Countries
United States
Sponsor
Icahn School of Medicine at Mount Sinai
Condition
Depression
Drug study icon
RecruitingNCT06633016

ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)

This observational study is following people with depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Autobahn Therapeutics, Inc.
Condition
Depression
Drug study icon
RecruitingNCT05850689

Lumateperone as Adjunctive Therapy in the Treatment of people with Major Depressive Disorder

This study is comparing Lumateperone with placebo for people with depression. Participants receive Lumateperone or placebo and complete study visits and assessments.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 65 Years
Countries
United States, France, Bulgaria, ...
Sponsor
Intra-Cellular Therapies, Inc.
Condition
Depression
Drug study icon
RecruitingNCT04480918

University of Iowa Interventional Psychiatry Service Patient Registry

This study is looking at examine the effects of interventional/procedural therapies for treatment-resistant depression (TRD) and OCD (OCD) for people with depression or bipolarity. Participants are followed over time so researchers can learn from clinical and follow-up information.

In United States
Why is this study shown?

This study is directly about Depression.

Depression, Bipolarity, ...DrugFrom 18 Years to 99 Years
Countries
United States
Sponsor
Mark Niciu
Condition
Depression, Bipolarity, ...
Drug study icon
RecruitingNCT06547489

Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

This study is comparing Zelquistinel with placebo for people with depression. Participants receive Zelquistinel or placebo and complete study visits and assessments.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 64 Years
Countries
United States
Sponsor
Syndeio Biosciences, Inc
Condition
Depression
Device study icon
Not Yet RecruitingNCT07680140

Biomarker-Guided Antidepressant Selection

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDeviceFrom 18 Years to 70 Years
Countries
United States
Sponsor
Weill Medical College of Cornell University
Condition
Depression
Drug study icon
Not Yet RecruitingNCT07623135

Lumateperone for Late-Life Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugOver 60 Years
Countries
United States
Sponsor
Eric Lenze
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.